by ASTCT Talks
In this episode of ASTCT Talks, Dr. Corey Cutler sits down with Dr. Ana Barata to discuss the critical role of physician-patient communication in GVHD and stem cell transplantation.
by Science
Researchers present evidence, collected from several tumor models in mice, demonstrating the benefits of inhibition of interferon γ (IFN-γ) signaling in the setting of both hematologic and solid...
by Science
Chimeric antigen receptor (CAR) T-cell efficacy against solid tumors has room for improvement, and researchers are exploring low-dose radiation as one possible pathway to better outcomes.
by The New England Journal of Medicine
Researchers believe an "armored" chimeric antigen receptor (CAR) T-cell product could achieve durable remission in lymphoma patients whose previous anti-CD19 CAR T therapy failed. In...
by Blood Advances
A retrospective analysis shows brexucabtagene autoleucel (brexu-cel), a chimeric antigen receptor (CAR) T-cell therapy, is safe and effective for people with relapsed/refractory B-cell acute...
by Alex Kadhim
Researchers at Beth Israel Deaconess Medical Center and collaborators have found thatdurable remission following CART-cell therapy (axicabtagene ciloleucel;Axi-cel) inpatients with...